IDEXX Reference Laboratories
DISCOVER MORE
IDEXX FGF-23 Test
A new method for managing and monitoring phosphorous overload in chronic kidney disease—now included in IRIS treatment recommendations for CKD in cats.
Early detection of phosphorous overload and metabolic bone disease in cats with IRIS CKD Stage 1 and Stage 21,2
Enables confident treatment recommendations, such as introducing a phosphate-restrictive diet
Enhanced view of a patient's kidney health — as an addition to IDEXX's suite of kidney health diagnostics, including the IDEXX SDMA Test
Support
Forms and other resources
Access IDEXX Reference Laboratories specimen guidelines, forms, articles, and more.
Directory of Tests and Services
Browse the online Directory of Tests and Services to see a comprehensive list of offerings from IDEXX Reference Laboratories.
IDEXXCare Plus
Keeping your practice up-to-date and running smoothly is the IDEXXCare Plus promise. We’re at your service 24 hours a day, 7 days a week, to help you deliver the best veterinary care and customer experiences possible.
Learn more about a specific product or service.
A representative will help you every step of the way.
IDEXX Reference Laboratories
DISCOVER MORE
References
- Geddes RF, Elliott J, Syme HM. Relationship between Plasma Fibroblast Growth Factor-23 concentration and Survival Time in Cats with Chronic Kidney Disease. J Vet Intern Med. 2015;29:1494-1501.
- Finch NC, Geddes RF, Syme HM, Elliott J. Fibroblast Growth Factor 23 (FGF-23) Concentrations in Cats with Early Nonazotemic Chronic Kidney Disease (CKD) and in Health Geriatric Cats. J Vet Intern Med. 2013;27:227-233